Middle East & Africa In Vitro Diagnostics Market

The Middle East & Africa in vitro diagnostics (IVD) market is expected to grow from USD 3.49 billion in 2026 to USD 4.42 billion by 2031, at a CAGR of 4.8%. The demand for diagnostic testing in healthcare settings is increasing, driving market growth by improving access to laboratory services. Additionally, heightened government focus on disease surveillance and early diagnosis, along with ongoing investments in healthcare infrastructure, are contributing to the widespread adoption of in vitro diagnostic solutions across the region.

In May 2023, DiaSorin S.p.A. (Italy) entered into a partnership with MeMed (Israel) by signing a distribution agreement for the MeMed BV test on the MeMed Key analytical platform in the Italian market through its subsidiary, DiaSorin Italia S.p.A.

To know about the assumptions considered for the study download the pdf brochure

In February 2022, Sysmex Corporation (Japan) expanded its presence in the Middle East by establishing its subsidiary, Sysmex LLC, in Saudi Arabia. This expansion was undertaken to strengthen the company’s sales and service structure in the region.

Companies such as F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), and QuidelOrtho Corporation (US) have adopted various strategies to expand their offerings and increase their market shares. These include collaborations with other companies, acquisitions, development of new products or services, and contractual agreements, among other approaches.

F. Hoffmann-La Roche Ltd. (Switzerland) holds a strong position in the Middle East & Africa IVD market, supported by a comprehensive portfolio that covers clinical chemistry, immunoassays, MDx, and POC testing, allowing it to meet a wide range of diagnostic requirements across the region. Its continued emphasis on product innovation, high-quality standards, and adherence to regulatory requirements, combined with a well-established regional distribution and service network, has helped build long-standing customer relationships and sustain its competitive standing across the Middle East & Africa.

Danaher (US) is one of the most prominent players in the Middle East & Africa IVD market because of its key focus and emphasis on innovative diagnostic solutions and scalable laboratory systems designed for high-throughput testing and decentralized testing sites. The company’s core strengths lie in automation, efficiency, and reliability in system functionality, thereby aligning perfectly with the rising testing volumes and requirements of the region’s healthcare landscape.

Market Ranking

F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Thermo Fisher Scientific Inc. (US), and Siemens Healthineers AG (Germany) are some key players in the in vitro diagnostics market across the Middle East & Africa because of their wide diagnostic portfolios and continuous technological improvements.

Roche is recognized for providing innovative molecular diagnostics, laboratory automation, and personalized healthcare solutions to support the testing of oncological diseases, diabetes, and other conditions. Abbott has established a strong market presence for immunoassays, point-of-care diagnostics, and clinical chemistry testing platforms. Danaher is a major provider of a very vast and broad range of diagnostic instruments, reagents, and workflow solutions, all supported by a very large global manufacturing and distribution network. Thermo Fisher Scientific strengthens the market with its extensive portfolio of diagnostic instruments, reagents, and laboratory systems used in routine and specialized clinical testing. Siemens Healthineers manufactures cutting-edge diagnostic innovations across immunoassays, hematology, and automated laboratory workflows, facilitating streamlined operations.

Related Reports:

Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com